Algernon Pharmaceuticals Inc. C.AGN

Alternate Symbol(s): AGNPF

Algernon Pharmaceuticals Inc. is a clinical-stage drug development company. The Company is focused on developing repurposed therapeutic drugs in the areas of non-alcoholic steatohepatitis (NASH), a type of liver disease, chronic kidney disease (CKD), inflammatory bowel disease (IBD), idiopathic pulmonary fibrosis (IPF) and chronic cough as well as advancing a stroke program using N, N-Dimethyltryptamine (DMT). The Company operates through two segments, which includes the development of repurposed therapeutic drugs in Canada and the facilitation of the Company’s lead drug candidates into off-label phase II clinical trials (humans) in Australia. The Company's pipeline includes NP-251 (Repirinast) and AP-188 (DMT). The Company, through its subsidiary, Algernon NeuroScience Inc., is developing AP-188 (DMT) as a potential treatment for stroke and traumatic brain injury (TBI) recovery. Its NP-251 is being developed as a potential treatment for kidney inflammation and fibrosis.

CSE:AGN - Post by User

Algernon Pharmaceuticals Inc.

<< Previous

Bullboard Posts

Next >>

Post by BlaineBorgon Jul 17, 2021 9:38am

376 Views

Post# 33564984

What's In A Company Name?

Let Christopher Moreau tell it, he and the Board Of Directors had to convince (arm twisting) the former CSO, Dr. Mark Williams, the name Algernon was a good idea. So what motivated the Board Of Directors tio name a company after a Science Fiction short story that doesn't end well?

How did Algernon die in Flowers for Algernon? | Study.com

"Algernon dies after suffering protracted symptoms of a widespread neurological collapse. The mouse loses the ability to moderate its behavior, followed by the loss of all memories. It experiences increasingly severe coordination problems. Charlie never states what caused the mouse's death, but it is clear that Algernon's death was directly connected to the experiment's sudden reversal. It is safe to assume that Charlie will eventually die of the same causes." - @ study.com

Yeah, it's all coming into focus now with Christoher Moreau at the helm guilding the story of Algernon Pharmaceuticals. It sure feel like he's skipping some happy chapters of the story and dived head first towards the end of the story. Meanwhile, the former CSO has moved on to name his own company Marvel Biotechnology.

What a Marvelous Idea.

BB

<< Previous

Bullboard Posts

Next >>

The Market Online’s Weekly Gold Report – Nov. 13, 2024